| Dr Traci Jo Bell, DC | |
|
7390 Business Center Dr, Avon, IN 46123-8662 | |
| (317) 272-7000 | |
| (317) 272-4302 |
| Full Name | Dr Traci Jo Bell |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 22 Years |
| Location | 7390 Business Center Dr, Avon, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982775466 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 08002062A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mohr Chiropractic Pc | 8022383439 | 3 |
News Archive
An analysis of data from more than 1,300 women followed prospectively through pregnancy found that women with lower levels of the essential mineral manganese in early pregnancy were more likely to develop the serious high blood pressure syndrome called preeclampsia in late pregnancy, according to a new study led by researchers from Johns Hopkins Bloomberg School of Public Health.
The Centers For Medicare & Medicaid Services said Friday that, because of data inconsistencies, a third of the records in a database showing drug and device-maker contributions to doctors will be withheld next month when the website goes live.
BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.
Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a - 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding - 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.
› Verified 6 days ago
| Provider Name | Mohr Chiropractic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225564842 PECOS PAC ID: 8022383439 Enrollment ID: O20171011002742 |
News Archive
An analysis of data from more than 1,300 women followed prospectively through pregnancy found that women with lower levels of the essential mineral manganese in early pregnancy were more likely to develop the serious high blood pressure syndrome called preeclampsia in late pregnancy, according to a new study led by researchers from Johns Hopkins Bloomberg School of Public Health.
The Centers For Medicare & Medicaid Services said Friday that, because of data inconsistencies, a third of the records in a database showing drug and device-maker contributions to doctors will be withheld next month when the website goes live.
BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.
Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a - 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding - 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Traci Jo Bell, DC 7390 Business Center Dr, Avon, IN 46123-8662 Ph: (317) 272-7000 | Dr Traci Jo Bell, DC 7390 Business Center Dr, Avon, IN 46123-8662 Ph: (317) 272-7000 |
News Archive
An analysis of data from more than 1,300 women followed prospectively through pregnancy found that women with lower levels of the essential mineral manganese in early pregnancy were more likely to develop the serious high blood pressure syndrome called preeclampsia in late pregnancy, according to a new study led by researchers from Johns Hopkins Bloomberg School of Public Health.
The Centers For Medicare & Medicaid Services said Friday that, because of data inconsistencies, a third of the records in a database showing drug and device-maker contributions to doctors will be withheld next month when the website goes live.
BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.
Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a - 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding - 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.
› Verified 6 days ago
Mrs. Amanda Kay Wyant, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2279 Gray Birch Ct, Avon, IN 46123 Phone: 636-577-3464 | |
Cornerstone Chiropractic, P C Chiropractor Medicare: Medicare Enrolled Practice Location: 5250 E Us Highway 36, Suite 140, Avon, IN 46123 Phone: 317-745-7700 Fax: 317-745-1230 | |
Dr. James B Keating Iii, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 97 Dover St, Suite 500, Avon, IN 46123 Phone: 317-600-3070 Fax: 317-268-6361 | |
Spinalcare Physical Medicine Chiropractor Medicare: Medicare Enrolled Practice Location: 7030 E Us Highway 36, Avon, IN 46123 Phone: 317-272-4100 | |
Dr. John C Anderson, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7390 Business Center Dr, Avon, IN 46123 Phone: 317-272-7000 Fax: 317-272-4302 | |
Dr. Justin David-gus Mohr, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 7390 Business Center Dr, Avon, IN 46123 Phone: 317-272-7000 Fax: 317-272-4302 | |
Mohr Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 7390 Business Center Dr, Avon, IN 46123 Phone: 317-272-7000 Fax: 317-272-4302 |